Showing 341 - 360 results of 102,716 for search '(( 30 point decrease ) OR ( 5 ((((wt decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.48s Refine Results
  1. 341

    Loss of ALS2 results in decreased levels of the lysosome-dependent degradation of LC3 in fibroblasts. by Shinji Hadano (251529)

    Published 2010
    “…It is notable that a 6 hr of starvation leads to decreased levels of the LC3- and p62-immunoreactive signals in WT cells, but not in <i>Als2</i><sup>−/−</sup> cells. …”
  2. 342

    AT1 receptor antagonism led to decreased expression of pro-fibrotic and pro-inflammatory factors in the kidney. by Anne-Cécile Huby (5653777)

    Published 2013
    “…Values are mean±SEM; n = 5, 9 and 13 for wild type and RenTg mice before and after irbesartan, respectively; * P<0,05 or ** P<0,01 vs WT; <sup>##</sup> P<0,01 vs RenTg.…”
  3. 343

    Expression of WT coilin or the OFF coilin mutant decreases cell proliferation in the presence of endogenous coilin. by Zunamys I. Carrero (342815)

    Published 2013
    “…Errors bars denote the percent standard error based on an n of no fewer than 5. There is a significant decrease (p value <0.05) in cell number upon the doxycycline induction of GFP-coilin WT or OFF mutant.…”
  4. 344
  5. 345
  6. 346
  7. 347

    Abhd15 expression is regulated during adipogenesis and decreased by elevated free fatty acid levels. by Evelyn Walenta (484072)

    Published 2013
    “…<b>E</b>. Mice fed a high fat diet (HFD, 60% calories in fat) show a decreased Abhd15 mRNA expression in WAT already after 3 days, but still after 15 weeks on this diet. …”
  8. 348
  9. 349
  10. 350
  11. 351
  12. 352
  13. 353
  14. 354
  15. 355
  16. 356
  17. 357
  18. 358
  19. 359
  20. 360

    Cdk5 siRNA knockdown decreased Cdk5 activity, diminished WT1 expression and viable cell numbers, and increased cleaved caspase 3 level. by Ya-Li Zheng (454837)

    Published 2016
    “…Western blotting analysis showed a decline of WT1 expression in Cdk5 siRNA podocytes (upper panel, lane 2). …”